Cargando…

Radiation-dependent demyelination in normal appearing white matter in glioma patients, determined using quantitative magnetic resonance imaging

BACKGROUND AND PURPOSE: A brain tumour, especially a glioma, is a rare disease; it is challenging to treat and the prognosis is often poor. Routine care includes surgery and concomitant chemoradiotherapy (CRT). Diagnostic work-up and treatment effects are typically evaluated using magnetic resonance...

Descripción completa

Detalles Bibliográficos
Autores principales: Ljusberg, Anna, Blystad, Ida, Lundberg, Peter, Adolfsson, Emelie, Tisell, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500023/
https://www.ncbi.nlm.nih.gov/pubmed/37720464
http://dx.doi.org/10.1016/j.phro.2023.100451
Descripción
Sumario:BACKGROUND AND PURPOSE: A brain tumour, especially a glioma, is a rare disease; it is challenging to treat and the prognosis is often poor. Routine care includes surgery and concomitant chemoradiotherapy (CRT). Diagnostic work-up and treatment effects are typically evaluated using magnetic resonance imaging (MRI). Quantitative MRI (qMRI), unlike conventional MRI, has the advantage of providing tissue-specific relaxation rates and proton density. The purpose is to detect changes in normal appearing white matter (NAWM) in brain tumour patients after CRT using qMRI. MATERIALS & METHODS: NAWM was analysed in 10 patients, in 83 MR examinations performed before and after surgery and after CRT. Relaxation rates R(1) and R(2), the proton density (PD) and the concentration of myelin (c(My)) were calculated from the qMRI scans and analysed in correlation to radiation dose and time after treatment. RESULTS: A significant decrease in c(My) between pre-treatment imaging and first follow-up and an increase in PD were observed. For low doses (less than 30 Gy) PD and c(My) returned to baseline (=pre-operative status), while for high doses (>30 Gy) the change increased during the full extent of the follow-up period. No difference could be established for R(1). For R(2) an increase was observed during the first year, which then gradually returned to baseline. For R(2), stronger effects were seen as a consequence of higher absorbed doses. CONCLUSION: In the long-term follow-up for glioma patients, qMRI is a powerful tool for detecting small changes, such as a decrease of myelin concentration, in NAWM after CRT.